Biotech · Private company · Rocky River, OH, US
Janusq, LLC
Track this companyFree. Adds Janusq, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV-3 for the Treatment of Huntington's diseaseFiscal year 2026 · $207.5KNIH RePORTER 5R43NS145846-02 · fetched Nov 12, 2026
- Pharmacokinetics and in vivo efficacy of DA1 macrocyclic peptides in a murine model of Alzheimer's diseaseFiscal year 2025 · $576.7KNIH RePORTER 1R43AG097351-01 · fetched Nov 12, 2026
- In vivo efficacy and in vitro toxicity assessment of peptide-based therapy HV-3 for the Treatment of Huntington's diseaseFiscal year 2025 · $490.5KNIH RePORTER 1R43NS145846-01 · fetched Nov 12, 2026